Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sanhua powder for injection
- Development stage
- Unknown
- Lead developer
- Shenzhen Yuanxing Biomedical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous
01
Overview
Sanhua Powder for Injection is a botanical drug candidate developed by Tsinghua Yuanxing Pharmaceutical for the treatment of cardiovascular and cerebrovascular conditions. Derived from traditional Chinese medicine (TCM), it is specifically being evaluated for indications including stroke sequelae, coronary heart disease, and angina pectoris. The drug is formulated as a lyophilized powder for reconstitution and intravenous administration. Clinical development has reached Phase I in China, where it has been studied for safety, tolerability, and to establish dosing regimens for subsequent clinical trials. As a TCM-derived product, it likely contains multiple active components intended to improve microcirculation and provide neuroprotective effects.
- Brand names
- Sanhua
- Other names
- 三花粉针
02
Targets
PTAFR (Platelet-activating factor receptor)
Beyond the preview
Go deeper on sanhua powder for injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sanhua powder for injection.